Journal of Cancer Research and Therapeutics Close
 

Figure 3: Connection between cell migration and pyruvate kinase M2. (a) Migration rate was measured after transfection. (b) Group SB203580 was transfected with inhibitor of p38; group small interfering-pyruvate kinase M2+ SB203580 was cells interfered by small interfering-pyruvate kinase M2 transfected with inhibitor of p38; group pyruvate kinase M2+ small interfering-pyruvate kinase M2+ SB203580 was cells interfered by small interfering-pyruvate kinase M2 and transfected with inhibitor of p38, following by overexpression of pyruvate kinase M2. **P < 0.01 and ***P < 0.001 compared with the control group

Figure 3: Connection between cell migration and pyruvate kinase M2. (a) Migration rate was measured after transfection. (b) Group SB203580 was transfected with inhibitor of p38; group small interfering-pyruvate kinase M2+ SB203580 was cells interfered by small interfering-pyruvate kinase M2 transfected with inhibitor of p38; group pyruvate kinase M2+ small interfering-pyruvate kinase M2+ SB203580 was cells interfered by small interfering-pyruvate kinase M2 and transfected with inhibitor of p38, following by overexpression of pyruvate kinase M2. **<i>P</i> < 0.01 and ***<i>P</i> < 0.001 compared with the control group